Daniela Agnew
Medical · Palm Desert, CANPI 1700274354
Payments from drug & device makers
Across 123 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$414
- Novo Nordisk$321
- Novartis$223
- Lilly USA, LLC$179
- AstraZeneca$160
- Biohaven Pharmaceutical Holding Company Ltd.$148
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,659100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 14 | $414 |
| Novo Nordisk | 19 | $321 |
| Novartis | 11 | $223 |
| Lilly USA, LLC | 7 | $179 |
| AstraZeneca | 10 | $160 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $148 |
| Johnson & Johnson | 3 | $129 |
| Bayer | 6 | $113 |
| AbbVie | 6 | $107 |
| E.r. Squibb & Sons, L.L.C. | 6 | $99 |
| Boehringer Ingelheim | 4 | $98 |
| Pfizer | 4 | $85 |
| Antares Pharma, Inc. | 3 | $65 |
| Idorsia Pharmaceuticals US Inc | 2 | $45 |
| Amgen | 2 | $40 |
| Cranial Technologies, Inc | 2 | $38 |
| GSK | 3 | $37 |
| Hikma Pharmaceuticals USA | 2 | $37 |
| Abbott | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Avion Pharmaceuticals | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Phadia US Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Merck | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Impel Pharmaceuticals Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $21 |
| Medtronic | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| Itamar Medical Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$254
- NURTEC ODT$124
- XARELTO$102
How this compares
$2,659 in reported general payments places this provider in the 75th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 36 | $40,286 |
| JardianceEmpagliflozin | 30 | $29,742 |
| TrulicityDulaglutide | 29 | $28,558 |
| SteglujanErtugliflozin/Sitagliptin Phos | 23 | $20,093 |
| JanuviaSitagliptin Phosphate | 17 | $12,324 |
| SteglatroErtugliflozin Pidolate | 12 | $4,817 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $1,559 |
| Atorvastatin Calcium | 108 | $1,306 |
| Losartan Potassium | 76 | $682 |
| Metformin Hcl | 93 | $609 |
| Rosuvastatin Calcium | 32 | $579 |
| Lisinopril | 75 | $482 |
| Tamsulosin Hcl | 36 | $476 |
| Metoprolol Succinate | 22 | $434 |
| Levothyroxine Sodium | 35 | $430 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $321 | $40,28636 claims |
| MerckSteglujan, Januvia, Steglatro | $22 | $37,23452 claims |
| Boehringer IngelheimJardiance | $98 | $29,74230 claims |
| Lilly USA, LLCTrulicity | $179 | $28,55829 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 medical providers in California.
Other medical in Palm Desert
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.